The meeting agenda is now available for the Newborn Screening Technical Advisory Committee meeting on Wednesday, July 7. We will meet 9:30 a.m. – 12:00 p.m. via the Zoom virtual meeting platform. This is the second meeting of the technical advisory committee. Meeting details are located on page two of the agenda.
To access the meeting:
- Join online: Click on the hyperlink: https://us02web.zoom.us/j/89977483277?pwd=M1J2NWpKbWpaWXhzZ25odUJyenNYQT09
- Join by phone: Dial-In: +1 (253) 215-8782 US (Tacoma) Access Code: 3456
The Washington State Board of Health (Board) has the authority to define and adopt rules for screening of Washington-born infants for hereditary conditions. WAC 246-650-010 defines the conditions and WAC 246-650-020 lists conditions for which all Washington-born newborns are to be screened. The Board convenes a technical advisory committee (TAC) in order to determine which conditions to include in the newborn screen (NBS) panel. The TAC evaluates candidate conditions using an established set of criteria. The purpose of this virtual meeting is to consider Ornithine Transcarbamylase Deficiency (OTCD) for inclusion on the newborn screening panel. If you have questions regarding this meeting, please email Samantha Pskowski, Board Policy Advisor, or call (360) 789-2358.
